Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

By S. Rana, Camille E. Powe, S. Salahuddin, S. Verlohren, F. Perschel, Richard J. Levine, K. Lim, Julia B. Wenger, R. Thadhani, S. Karumanchi. Circulation, 2012

619 citations recorded by the source corpus.

Subfields: Immunology, Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/880900cc4f835f00ac23d89479c33c85fa6ae8c8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Magee
2. M. Brown
3. D. Hall
4. S. Gupte
5. Mark A. Brown
6. A. Hennessy
7. S. Karumanchi
8. Laura A. Magee

Citations in the corpus

• Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. (2018, background): “Measurement of angiogenic factors may play a role in this regard in the future but is still at a research stage.(56)”
• The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. (2018, background): “Measurement of angiogenic factors may play a role in this regard in the future but is still at a research stage(56).”
• The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. (2021, background): “…has high negative predictive value in ruling out: development of proteinuric pre-eclampsia within 7 days, adverse maternal outcomes within 14 days [46], or delivery with pre-eclampsia within 14 days [37 – 38] when suspected pre-eclampsia is primarily related to hypertension (but not when FGR is a…”